Notably, the t (4; 14) NSD2 translocation in multiple myeloma and the hyperactive NSD2 mutation E1099K in a subset of pediatric acute lymphoblastic leukemia result in altered chromatin methylation that drives oncogenesis (Keats et al., 2003; Jaffe et al., 2013). Here, NSD2 is linked to AL amyloidosis.